Arq. Bras. Oftalmol. 2022; 85 (2): 10.5935/0004-2749.20220017
Total: 2931
Martín Berra1; Gustavo Galperín1; Federico Berra2; Maria Isabel Marquez2; Mariana Mandaradoni3; Julia Tau4; Alejandro Berra4
DOI: 10.5935/0004-2749.20220017
1. Hospital Oftalmológico “Pedro Lagleyze”, Buenos Aires, Argentina
2. Bioquímica Ocular, Buenos Aires, Argentina
3. Hospital Posadas Buenos Aires, Argentina
4. Laboratorio Traslacional de Inmunopatologia & Oftalmologia, Departamento de Patologia, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina
Martín Berra
E-mail: [email protected]
Funding: This study received no specific financial support
Disclosure of potential conflicts of interest: None of the authors have any potential conflicts of interest to disclose
How to cite this article: